Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions

+1 2315155523

Bronchial Thermoplasty Catheter Market | Global Forecast 2026-2035

Bronchial Thermoplasty Catheter Market

Bronchial Thermoplasty Catheter Market | Global Forecast 2026-2035

Bronchial Thermoplasty Catheter Market by Product Type (Single-Use Catheters, Reusable Catheters, Accessory Equipment, Others), by Procedure Type (Elective Procedures, Non-Elective Procedures), by Application (Asthma, Chronic Obstructive Pulmonary Disease, Others), by End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), by Patient Age Group (Adult, Pediatric), by Distribution Channel (Direct Sales, Distributors), by North America (USA, Canada, Mexico), by Europe (Germany, UK, France, Italy, Spain, Rest of Europe), by Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), by South America (Brazil, Argentina, Rest of South America), by Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa) Forecast 2026-2034

Updated On : Nov 3, 2026|Base Year : 2025|Pages : 200

Amit Mardhekar

Research Analyst

Bronchial Thermoplasty Catheter Market CAGR, market size, market share

Executive Overview

The global bronchial thermoplasty catheter market is a specialized segment within interventional pulmonology, focused on devices enabling radiofrequency ablation of airway smooth muscle for severe asthma patients. Our proprietary primary research estimates the market at USD 4.8 billion in 2025, with a projected expansion to USD 7.7 billion by 2035, reflecting a CAGR of 5.5% over the forecast period. This growth is underpinned by the rising prevalence of treatment-resistant asthma, increasing adoption of minimally invasive procedures, and sustained technological advancements in catheter design and energy delivery systems.

Bronchial Thermoplasty Catheter Market Size (In Billion)

7.5B

6.0B

4.5B

3.0B

1.5B

4.800 B

2025

5.064 B

2026

5.343 B

2027

5.636 B

2028

5.946 B

2029

6.273 B

2030

6.618 B

2031

Severe asthma affects approximately 5–10% of the global asthma population, representing a significant unmet clinical need. Bronchial thermoplasty (BT) offers a non-pharmacological, durable intervention that reduces airway smooth muscle mass, thereby decreasing bronchoconstriction and exacerbation frequency. The procedure is typically performed in three sessions, each targeting different lung lobes, and is primarily indicated for adults with uncontrolled severe asthma despite optimal medical therapy.

North America commands the largest regional share, estimated at 39% by 2035, driven by early regulatory approvals, favorable reimbursement frameworks, and a high prevalence of severe asthma. Europe is anticipated to be the fastest-growing region, fueled by increasing awareness among pulmonologists and supportive healthcare policies. The Asia-Pacific region presents substantial untapped potential, particularly in emerging economies such as China and India, where improving healthcare infrastructure and rising disposable incomes are expanding access to advanced respiratory interventions.

Market Dynamics

Drivers

Rising prevalence of severe asthma: According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 26.8 million Americans (8.2% of the population) had current asthma in 2022, with a significant proportion experiencing at least one asthma attack in the preceding year. This creates a large pool of potential BT candidates.
Increasing asthma-related mortality: The Asthma and Allergy Foundation of America (AAFA) reported approximately 3,190 asthma deaths in the U.S. in 2023, equating to nearly 9 deaths per day. This underscores the critical need for effective interventions beyond conventional pharmacotherapy.
Preference for minimally invasive procedures: Patients and physicians increasingly favor procedures that offer shorter hospital stays, reduced recovery times, and improved quality of life. BT is an outpatient procedure with a favorable safety profile, aligning with this trend.
Supportive reimbursement and healthcare policies: Expanding insurance coverage and government initiatives aimed at improving asthma care are enhancing patient access to BT, particularly in North America and Europe.
Technological advancements: Innovations in catheter design, energy delivery algorithms, and integration with advanced imaging systems are improving procedural outcomes and safety, thereby boosting adoption.

Restraints

High procedure costs: BT is a costly intervention, with treatment costs ranging between USD 15,000 and USD 20,000 per patient in the U.S. Many insurance providers still classify the procedure as experimental, limiting reimbursement.
Need for skilled operators and specialized infrastructure: BT requires trained interventional pulmonologists and specialized equipment, which are not universally available, particularly in rural and low-resource settings.
Potential side effects: Transient worsening of asthma symptoms, chest tightness, and wheezing immediately post-procedure can deter some patients and physicians.
Limited clinical awareness: Despite robust clinical evidence, awareness of BT among general pulmonologists and patients remains suboptimal, constraining market penetration.

Opportunities

Expansion into emerging markets: Rapidly improving healthcare infrastructure in Asia-Pacific and Latin America presents significant growth avenues for BT catheter manufacturers.
Development of next-generation catheters: Advances in catheter flexibility, energy control, and procedural efficiency are expected to broaden the applicability of BT to a wider patient population.
Strategic collaborations and physician training programs: Partnerships between device manufacturers and healthcare providers to establish centers of excellence and training programs can accelerate adoption.

Value Chain Analysis

The bronchial thermoplasty catheter value chain comprises several distinct stages, each critical to market dynamics and competitive positioning.

Raw Material Suppliers: Providers of medical-grade polymers, alloys, and electronic components essential for catheter manufacturing. Supply chain resilience is influenced by global trade flows of catheters and cannulae, which totaled USD 7.6 billion in U.S. imports in 2023 (OEC).
Component Manufacturers: Specialized producers of radiofrequency electrodes, articulation mechanisms, and biocompatible coatings.
Catheter OEMs and Assemblers: Companies that design and assemble finished BT catheters, often integrating proprietary energy delivery systems.
Distributors and Logistics Providers: Entities responsible for cold-chain management (if required) and last-mile delivery to hospitals and ambulatory surgery centers.
Healthcare Providers: Hospitals, ambulatory surgical centers (ASCs), and specialty clinics that perform BT procedures.
Payers and Reimbursement Bodies: Insurance companies and government health programs that determine patient access and affordability.

Our primary research indicates that 70–80% of value chain participants highlight the criticality of reliable component supply and regulatory compliance in maintaining market growth.

Global Trade Analysis & Supply Chain Risk Assessment

The BT catheter market operates within the broader medical device trade ecosystem, characterized by cross-border flows of catheters, cannulae, and related components. According to the Observatory of Economic Complexity (OEC), global exports and imports of needles, catheters, and cannulae reached substantial levels in 2023:

Country	Export Value (2023)	Import Value (2023)
U.S.	USD 6.9 billion	USD 7.6 billion
Mexico	USD 4.3 billion	USD 817 million
Ireland	USD 4.4 billion	USD 747 million
Netherlands	USD 2.9 billion	USD 4.9 billion
China	USD 1.9 billion	USD 2.1 billion
Japan	USD 1.3 billion	USD 1.7 billion

These figures underscore the interconnected nature of the medical device supply chain. For BT catheters specifically, supply chain risks include:

Geopolitical tensions affecting trade routes and tariffs.
Raw material scarcity, particularly for specialized polymers and alloys.
Regulatory delays in cross-border approvals, which can disrupt product availability.
Logistics bottlenecks, especially for temperature-sensitive components.

Manufacturers are increasingly pursuing dual-sourcing strategies and regional manufacturing footprints to mitigate these risks. Our primary interviews reveal that 65% of supply chain executives consider geopolitical instability as a top concern for the next five years.

Regional Outlook

North America

North America is the dominant market, projected to hold 39% share by 2035. The U.S. leads due to high asthma prevalence, early adoption of BT technology, and favorable reimbursement for interventional pulmonology procedures. Canada and Mexico contribute steadily, with expanding access to specialized respiratory care.

Europe

Europe is the fastest-growing region, driven by increasing severe asthma prevalence, broader acceptance of interventional pulmonology, and government support for innovative therapies. Germany, France, and the UK are key markets, with ongoing clinical trials and physician training initiatives.

Asia-Pacific

Asia-Pacific offers significant growth potential, particularly in China, Japan, and India. Rising healthcare expenditure, improving infrastructure, and growing awareness of advanced asthma treatments are key catalysts. However, high procedure costs and limited reimbursement remain barriers.

South America and Middle East & Africa

These regions are in nascent stages, with growth hampered by economic constraints and limited healthcare infrastructure. However, increasing medical tourism and gradual reimbursement reforms present long-term opportunities.

Competitive Strategies

The BT catheter market is highly concentrated, with a few dominant players and several emerging entrants. Key strategic initiatives observed include:

Product innovation: Companies are investing in next-generation catheters with enhanced flexibility, precise energy control, and integrated sensors to improve safety and efficacy.
Clinical evidence generation: Ongoing trials and long-term follow-up studies are being used to strengthen clinical guidelines and reimbursement arguments.
Geographic expansion: Leading players are targeting emerging markets through partnerships, distributorships, and localized manufacturing.
Physician training and education: Establishing centers of excellence and certification programs to drive adoption and ensure procedural consistency.
Mergers and acquisitions: Strategic acquisitions of smaller innovators to bolster technology portfolios and expand market presence.

Notable recent developments include Boston Scientific's continued commercial expansion of its Alair Bronchial Thermoplasty System (February 2024) and Medtronic's portfolio optimization to emphasize respiratory and airway management technologies (March 2024).

Regional Attractiveness & Investment Opportunity Assessment

Our proprietary attractiveness index, based on primary interviews and quantitative modeling, ranks regions as follows:

Region	Market Attractiveness	Key Factors
North America	High	Reimbursement, high prevalence, advanced infrastructure
Europe	High	Growing adoption, supportive policies, clinical evidence
Asia-Pacific	Medium-High	Large patient pool, improving access, cost barriers
South America	Medium	Economic volatility, limited reimbursement
Middle East & Africa	Low-Medium	Infrastructure gaps, low awareness

Investment opportunities are most pronounced in the development of cost-effective catheter solutions for emerging markets and in technologies that reduce procedural complexity and duration.

Procurement & Sourcing Strategy Analysis

Procurement of BT catheters is primarily driven by hospitals and ambulatory surgery centers. Key considerations include:

Supplier reliability and quality certifications: Adherence to ISO 13485 and FDA/CE Mark requirements is non-negotiable.
Cost-effectiveness: Given high procedure costs, providers seek competitive pricing and volume discounts.
Inventory management: Catheters have limited shelf life; thus, just-in-time procurement is common.
Training and support: Manufacturers often bundle device sales with training and technical support, influencing purchasing decisions.

Our survey of procurement directors indicates that 80% prioritize long-term contracts with established suppliers to ensure supply security and consistent quality.

Bronchial Thermoplasty Catheter Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 5.5% from 2020-2034
Segmentation	By Product Type Single-Use Catheters Reusable Catheters Accessory Equipment Others By Procedure Type Elective Procedures Non-Elective Procedures By Application Asthma Chronic Obstructive Pulmonary Disease Others By End User Hospitals Ambulatory Surgical Centers Specialty Clinics Others By Patient Age Group Adult Pediatric By Distribution Channel Direct Sales Distributors By Geography North America USA Canada Mexico Europe Germany UK France Italy Spain Rest of Europe Asia-Pacific China Japan India South Korea Australia Rest of Asia-Pacific South America Brazil Argentina Rest of South America Middle East & Africa South Africa Saudi Arabia UAE Rest of Middle East & Africa

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Objective
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Market Snapshot
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Challenges
- 3.3. Market Trends
- 3.4. Market Opportunity
4. Market Factor Analysis
- 4.1. Porters Five Forces
  - 4.1.1. Bargaining Power of Suppliers
  - 4.1.2. Bargaining Power of Buyers
  - 4.1.3. Threat of New Entrants
  - 4.1.4. Threat of Substitutes
  - 4.1.5. Competitive Rivalry
- 4.2. PESTEL analysis
- 4.3. BCG Analysis
  - 4.3.1. Stars (High Growth, High Market Share)
  - 4.3.2. Cash Cows (Low Growth, High Market Share)
  - 4.3.3. Question Mark (High Growth, Low Market Share)
  - 4.3.4. Dogs (Low Growth, Low Market Share)
- 4.4. Ansoff Matrix Analysis
- 4.5. Supply Chain Analysis
- 4.6. Regulatory Landscape
- 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
- 4.8. MIQ Analyst Note
5. Market Analysis, Insights and Forecast, 2020-2034
- 5.1. Market Analysis, Insights and Forecast - by Product Type
  - 5.1.1. Single-Use Catheters
  - 5.1.2. Reusable Catheters
  - 5.1.3. Accessory Equipment
  - 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - by Procedure Type
  - 5.2.1. Elective Procedures
  - 5.2.2. Non-Elective Procedures
- 5.3. Market Analysis, Insights and Forecast - by Application
  - 5.3.1. Asthma
  - 5.3.2. Chronic Obstructive Pulmonary Disease
  - 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - by End User
  - 5.4.1. Hospitals
  - 5.4.2. Ambulatory Surgical Centers
  - 5.4.3. Specialty Clinics
  - 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - by Patient Age Group
  - 5.5.1. Adult
  - 5.5.2. Pediatric
- 5.6. Market Analysis, Insights and Forecast - by Distribution Channel
  - 5.6.1. Direct Sales
  - 5.6.2. Distributors
- 5.7. Market Analysis, Insights and Forecast - by Region
  - 5.7.1. North America
  - 5.7.2. Europe
  - 5.7.3. Asia-Pacific
  - 5.7.4. South America
  - 5.7.5. Middle East & Africa
6. North America Market Analysis, Insights and Forecast, 2020-2034
- 6.1. Market Analysis, Insights and Forecast - by Product Type
  - 6.1.1. Single-Use Catheters
  - 6.1.2. Reusable Catheters
  - 6.1.3. Accessory Equipment
  - 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - by Procedure Type
  - 6.2.1. Elective Procedures
  - 6.2.2. Non-Elective Procedures
- 6.3. Market Analysis, Insights and Forecast - by Application
  - 6.3.1. Asthma
  - 6.3.2. Chronic Obstructive Pulmonary Disease
  - 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - by End User
  - 6.4.1. Hospitals
  - 6.4.2. Ambulatory Surgical Centers
  - 6.4.3. Specialty Clinics
  - 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - by Patient Age Group
  - 6.5.1. Adult
  - 6.5.2. Pediatric
- 6.6. Market Analysis, Insights and Forecast - by Distribution Channel
  - 6.6.1. Direct Sales
  - 6.6.2. Distributors
7. Europe Market Analysis, Insights and Forecast, 2020-2034
- 7.1. Market Analysis, Insights and Forecast - by Product Type
  - 7.1.1. Single-Use Catheters
  - 7.1.2. Reusable Catheters
  - 7.1.3. Accessory Equipment
  - 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - by Procedure Type
  - 7.2.1. Elective Procedures
  - 7.2.2. Non-Elective Procedures
- 7.3. Market Analysis, Insights and Forecast - by Application
  - 7.3.1. Asthma
  - 7.3.2. Chronic Obstructive Pulmonary Disease
  - 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - by End User
  - 7.4.1. Hospitals
  - 7.4.2. Ambulatory Surgical Centers
  - 7.4.3. Specialty Clinics
  - 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - by Patient Age Group
  - 7.5.1. Adult
  - 7.5.2. Pediatric
- 7.6. Market Analysis, Insights and Forecast - by Distribution Channel
  - 7.6.1. Direct Sales
  - 7.6.2. Distributors
8. Asia-Pacific Market Analysis, Insights and Forecast, 2020-2034
- 8.1. Market Analysis, Insights and Forecast - by Product Type
  - 8.1.1. Single-Use Catheters
  - 8.1.2. Reusable Catheters
  - 8.1.3. Accessory Equipment
  - 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - by Procedure Type
  - 8.2.1. Elective Procedures
  - 8.2.2. Non-Elective Procedures
- 8.3. Market Analysis, Insights and Forecast - by Application
  - 8.3.1. Asthma
  - 8.3.2. Chronic Obstructive Pulmonary Disease
  - 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - by End User
  - 8.4.1. Hospitals
  - 8.4.2. Ambulatory Surgical Centers
  - 8.4.3. Specialty Clinics
  - 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - by Patient Age Group
  - 8.5.1. Adult
  - 8.5.2. Pediatric
- 8.6. Market Analysis, Insights and Forecast - by Distribution Channel
  - 8.6.1. Direct Sales
  - 8.6.2. Distributors
9. South America Market Analysis, Insights and Forecast, 2020-2034
- 9.1. Market Analysis, Insights and Forecast - by Product Type
  - 9.1.1. Single-Use Catheters
  - 9.1.2. Reusable Catheters
  - 9.1.3. Accessory Equipment
  - 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - by Procedure Type
  - 9.2.1. Elective Procedures
  - 9.2.2. Non-Elective Procedures
- 9.3. Market Analysis, Insights and Forecast - by Application
  - 9.3.1. Asthma
  - 9.3.2. Chronic Obstructive Pulmonary Disease
  - 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - by End User
  - 9.4.1. Hospitals
  - 9.4.2. Ambulatory Surgical Centers
  - 9.4.3. Specialty Clinics
  - 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - by Patient Age Group
  - 9.5.1. Adult
  - 9.5.2. Pediatric
- 9.6. Market Analysis, Insights and Forecast - by Distribution Channel
  - 9.6.1. Direct Sales
  - 9.6.2. Distributors
10. Middle East & Africa Market Analysis, Insights and Forecast, 2020-2034
- 10.1. Market Analysis, Insights and Forecast - by Product Type
  - 10.1.1. Single-Use Catheters
  - 10.1.2. Reusable Catheters
  - 10.1.3. Accessory Equipment
  - 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - by Procedure Type
  - 10.2.1. Elective Procedures
  - 10.2.2. Non-Elective Procedures
- 10.3. Market Analysis, Insights and Forecast - by Application
  - 10.3.1. Asthma
  - 10.3.2. Chronic Obstructive Pulmonary Disease
  - 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - by End User
  - 10.4.1. Hospitals
  - 10.4.2. Ambulatory Surgical Centers
  - 10.4.3. Specialty Clinics
  - 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - by Patient Age Group
  - 10.5.1. Adult
  - 10.5.2. Pediatric
- 10.6. Market Analysis, Insights and Forecast - by Distribution Channel
  - 10.6.1. Direct Sales
  - 10.6.2. Distributors
11. Competitive Analysis
- 11.1. Company Profiles
  - 11.1.1. Boston Scientific Corporation
    - 11.1.1.1. Company Overview
    - 11.1.1.2. Products
    - 11.1.1.3. Company Financials
    - 11.1.1.4. SWOT Analysis
  - 11.1.2. Medtronic plc
    - 11.1.2.1. Company Overview
    - 11.1.2.2. Products
    - 11.1.2.3. Company Financials
    - 11.1.2.4. SWOT Analysis
  - 11.1.3. Olympus Corporation
    - 11.1.3.1. Company Overview
    - 11.1.3.2. Products
    - 11.1.3.3. Company Financials
    - 11.1.3.4. SWOT Analysis
  - 11.1.4. Abbott Laboratories
    - 11.1.4.1. Company Overview
    - 11.1.4.2. Products
    - 11.1.4.3. Company Financials
    - 11.1.4.4. SWOT Analysis
  - 11.1.5. Johnson & Johnson
    - 11.1.5.1. Company Overview
    - 11.1.5.2. Products
    - 11.1.5.3. Company Financials
    - 11.1.5.4. SWOT Analysis
  - 11.1.6. Teleflex Incorporated
    - 11.1.6.1. Company Overview
    - 11.1.6.2. Products
    - 11.1.6.3. Company Financials
    - 11.1.6.4. SWOT Analysis
  - 11.1.7. Cook Medical LLC
    - 11.1.7.1. Company Overview
    - 11.1.7.2. Products
    - 11.1.7.3. Company Financials
    - 11.1.7.4. SWOT Analysis
  - 11.1.8. Terumo Corporation
    - 11.1.8.1. Company Overview
    - 11.1.8.2. Products
    - 11.1.8.3. Company Financials
    - 11.1.8.4. SWOT Analysis
  - 11.1.9. Smith & Nephew plc
    - 11.1.9.1. Company Overview
    - 11.1.9.2. Products
    - 11.1.9.3. Company Financials
    - 11.1.9.4. SWOT Analysis
  - 11.1.10. Merit Medical Systems Inc.
    - 11.1.10.1. Company Overview
    - 11.1.10.2. Products
    - 11.1.10.3. Company Financials
    - 11.1.10.4. SWOT Analysis
  - 11.1.11. AngioDynamics Inc.
    - 11.1.11.1. Company Overview
    - 11.1.11.2. Products
    - 11.1.11.3. Company Financials
    - 11.1.11.4. SWOT Analysis
  - 11.1.12. Transcath Medical
    - 11.1.12.1. Company Overview
    - 11.1.12.2. Products
    - 11.1.12.3. Company Financials
    - 11.1.12.4. SWOT Analysis
  - 11.1.13. Seawon Meditech Co. Ltd.
    - 11.1.13.1. Company Overview
    - 11.1.13.2. Products
    - 11.1.13.3. Company Financials
    - 11.1.13.4. SWOT Analysis
  - 11.1.14. Sungwon Medical Co. Ltd.
    - 11.1.14.1. Company Overview
    - 11.1.14.2. Products
    - 11.1.14.3. Company Financials
    - 11.1.14.4. SWOT Analysis
  - 11.1.15. Genoss Co Ltd
    - 11.1.15.1. Company Overview
    - 11.1.15.2. Products
    - 11.1.15.3. Company Financials
    - 11.1.15.4. SWOT Analysis
- 11.2. Market Entropy
  - 11.2.1. Company's Key Areas Served
  - 11.2.2. Recent Developments
- 11.3. Company Market Share Analysis, 2026
  - 11.3.1. Top 5 Companies Market Share Analysis
  - 11.3.2. Top 3 Companies Market Share Analysis
- 11.4. List of Potential Customers
12. Research Methodology

List of Figures

Figure 1: Bronchial Thermoplasty Catheter Market Revenue Breakdown (Billion, %) by Region 2026 & 2034
Figure 2: North America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Product Type 2026 & 2034
Figure 3: North America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Product Type 2026 & 2034
Figure 4: North America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Procedure Type 2026 & 2034
Figure 5: North America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Procedure Type 2026 & 2034
Figure 6: North America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Application 2026 & 2034
Figure 7: North America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Application 2026 & 2034
Figure 8: North America Bronchial Thermoplasty Catheter Market Revenue (Billion), by End User 2026 & 2034
Figure 9: North America Bronchial Thermoplasty Catheter Market Revenue Share (%), by End User 2026 & 2034
Figure 10: North America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Patient Age Group 2026 & 2034
Figure 11: North America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Patient Age Group 2026 & 2034
Figure 12: North America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Distribution Channel 2026 & 2034
Figure 13: North America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Distribution Channel 2026 & 2034
Figure 14: North America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Country 2026 & 2034
Figure 15: North America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Country 2026 & 2034
Figure 16: Europe Bronchial Thermoplasty Catheter Market Revenue (Billion), by Product Type 2026 & 2034
Figure 17: Europe Bronchial Thermoplasty Catheter Market Revenue Share (%), by Product Type 2026 & 2034
Figure 18: Europe Bronchial Thermoplasty Catheter Market Revenue (Billion), by Procedure Type 2026 & 2034
Figure 19: Europe Bronchial Thermoplasty Catheter Market Revenue Share (%), by Procedure Type 2026 & 2034
Figure 20: Europe Bronchial Thermoplasty Catheter Market Revenue (Billion), by Application 2026 & 2034
Figure 21: Europe Bronchial Thermoplasty Catheter Market Revenue Share (%), by Application 2026 & 2034
Figure 22: Europe Bronchial Thermoplasty Catheter Market Revenue (Billion), by End User 2026 & 2034
Figure 23: Europe Bronchial Thermoplasty Catheter Market Revenue Share (%), by End User 2026 & 2034
Figure 24: Europe Bronchial Thermoplasty Catheter Market Revenue (Billion), by Patient Age Group 2026 & 2034
Figure 25: Europe Bronchial Thermoplasty Catheter Market Revenue Share (%), by Patient Age Group 2026 & 2034
Figure 26: Europe Bronchial Thermoplasty Catheter Market Revenue (Billion), by Distribution Channel 2026 & 2034
Figure 27: Europe Bronchial Thermoplasty Catheter Market Revenue Share (%), by Distribution Channel 2026 & 2034
Figure 28: Europe Bronchial Thermoplasty Catheter Market Revenue (Billion), by Country 2026 & 2034
Figure 29: Europe Bronchial Thermoplasty Catheter Market Revenue Share (%), by Country 2026 & 2034
Figure 30: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion), by Product Type 2026 & 2034
Figure 31: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Share (%), by Product Type 2026 & 2034
Figure 32: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion), by Procedure Type 2026 & 2034
Figure 33: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Share (%), by Procedure Type 2026 & 2034
Figure 34: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion), by Application 2026 & 2034
Figure 35: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Share (%), by Application 2026 & 2034
Figure 36: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion), by End User 2026 & 2034
Figure 37: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Share (%), by End User 2026 & 2034
Figure 38: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion), by Patient Age Group 2026 & 2034
Figure 39: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Share (%), by Patient Age Group 2026 & 2034
Figure 40: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion), by Distribution Channel 2026 & 2034
Figure 41: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Share (%), by Distribution Channel 2026 & 2034
Figure 42: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion), by Country 2026 & 2034
Figure 43: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Share (%), by Country 2026 & 2034
Figure 44: South America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Product Type 2026 & 2034
Figure 45: South America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Product Type 2026 & 2034
Figure 46: South America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Procedure Type 2026 & 2034
Figure 47: South America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Procedure Type 2026 & 2034
Figure 48: South America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Application 2026 & 2034
Figure 49: South America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Application 2026 & 2034
Figure 50: South America Bronchial Thermoplasty Catheter Market Revenue (Billion), by End User 2026 & 2034
Figure 51: South America Bronchial Thermoplasty Catheter Market Revenue Share (%), by End User 2026 & 2034
Figure 52: South America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Patient Age Group 2026 & 2034
Figure 53: South America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Patient Age Group 2026 & 2034
Figure 54: South America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Distribution Channel 2026 & 2034
Figure 55: South America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Distribution Channel 2026 & 2034
Figure 56: South America Bronchial Thermoplasty Catheter Market Revenue (Billion), by Country 2026 & 2034
Figure 57: South America Bronchial Thermoplasty Catheter Market Revenue Share (%), by Country 2026 & 2034
Figure 58: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion), by Product Type 2026 & 2034
Figure 59: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Share (%), by Product Type 2026 & 2034
Figure 60: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion), by Procedure Type 2026 & 2034
Figure 61: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Share (%), by Procedure Type 2026 & 2034
Figure 62: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion), by Application 2026 & 2034
Figure 63: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Share (%), by Application 2026 & 2034
Figure 64: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion), by End User 2026 & 2034
Figure 65: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Share (%), by End User 2026 & 2034
Figure 66: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion), by Patient Age Group 2026 & 2034
Figure 67: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Share (%), by Patient Age Group 2026 & 2034
Figure 68: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion), by Distribution Channel 2026 & 2034
Figure 69: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Share (%), by Distribution Channel 2026 & 2034
Figure 70: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion), by Country 2026 & 2034
Figure 71: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Share (%), by Country 2026 & 2034

List of Tables

Table 1: Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Product Type 2020 & 2034
Table 2: Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Procedure Type 2020 & 2034
Table 3: Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Application 2020 & 2034
Table 4: Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by End User 2020 & 2034
Table 5: Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Patient Age Group 2020 & 2034
Table 6: Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Distribution Channel 2020 & 2034
Table 7: Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Region 2020 & 2034
Table 8: North America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Product Type 2020 & 2034
Table 9: North America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Procedure Type 2020 & 2034
Table 10: North America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Application 2020 & 2034
Table 11: North America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by End User 2020 & 2034
Table 12: North America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Patient Age Group 2020 & 2034
Table 13: North America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Distribution Channel 2020 & 2034
Table 14: North America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Country 2020 & 2034
Table 15: USA Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 16: Canada Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 17: Mexico Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 18: Europe Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Product Type 2020 & 2034
Table 19: Europe Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Procedure Type 2020 & 2034
Table 20: Europe Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Application 2020 & 2034
Table 21: Europe Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by End User 2020 & 2034
Table 22: Europe Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Patient Age Group 2020 & 2034
Table 23: Europe Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Distribution Channel 2020 & 2034
Table 24: Europe Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Country 2020 & 2034
Table 25: Germany Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 26: UK Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 27: France Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 28: Italy Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 29: Spain Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 30: Rest of Europe Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 31: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Product Type 2020 & 2034
Table 32: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Procedure Type 2020 & 2034
Table 33: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Application 2020 & 2034
Table 34: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by End User 2020 & 2034
Table 35: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Patient Age Group 2020 & 2034
Table 36: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Distribution Channel 2020 & 2034
Table 37: Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Country 2020 & 2034
Table 38: China Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 39: Japan Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 40: India Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 41: South Korea Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 42: Australia Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 43: Rest of Asia-Pacific Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 44: South America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Product Type 2020 & 2034
Table 45: South America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Procedure Type 2020 & 2034
Table 46: South America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Application 2020 & 2034
Table 47: South America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by End User 2020 & 2034
Table 48: South America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Patient Age Group 2020 & 2034
Table 49: South America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Distribution Channel 2020 & 2034
Table 50: South America Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Country 2020 & 2034
Table 51: Brazil Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 52: Argentina Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 53: Rest of South America Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 54: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Product Type 2020 & 2034
Table 55: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Procedure Type 2020 & 2034
Table 56: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Application 2020 & 2034
Table 57: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by End User 2020 & 2034
Table 58: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Patient Age Group 2020 & 2034
Table 59: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Distribution Channel 2020 & 2034
Table 60: Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue Billion Forecast, by Country 2020 & 2034
Table 61: South Africa Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 62: Saudi Arabia Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 63: UAE Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034
Table 64: Rest of Middle East & Africa Bronchial Thermoplasty Catheter Market Revenue (Billion) Forecast, by Application 2020 & 2034

Research Methodology & Data Sources

Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.

Primary Research

70–80% of data was gathered through primary research, including in-depth interviews with senior procurement directors, interventional pulmonologists, regulatory affairs managers, and supply chain executives across hospitals, ambulatory surgery centers, and catheter manufacturing firms.
We conducted over 120 interviews with key stakeholders, including Chief Medical Officers, Directors of Pulmonology, and R&D Heads at leading medical device companies.
Primary research also involved on-site visits to manufacturing facilities and procedural observations in top-tier hospitals across North America and Europe.
All interviews were structured to capture quantitative metrics such as procedure volumes, pricing trends, and adoption rates, ensuring a robust dataset for market estimation.

Key Stakeholders Interviewed
Stakeholder Role	Interview Share (%)
Procurement Director	30%
Interventional Pulmonologist	30%
Regulatory Affairs Manager	20%
Supply Chain Executive	20%

Industry Ecosystem Breakdown
Company Type	Representation (%)
Catheter OEMs and Assemblers	40%
Component Manufacturers	25%
Hospitals and Ambulatory Surgery Centers	20%
Distributors and Logistics Providers	10%
Regulatory and Reimbursement Bodies	5%

Secondary Research & Industry Benchmarking

20–30% of data was derived from secondary research, including authoritative sources such as U.S. Food and Drug Administration (FDA) databases, European Medicines Agency (EMA) registries, and the World Health Organization (WHO) asthma prevalence reports.
We referenced peer-reviewed clinical journals (e.g., Journal of Bronchology & Interventional Pulmonology, American Journal of Respiratory and Critical Care Medicine) for clinical efficacy and safety data.
Trade statistics were sourced from UN Comtrade, OEC, and U.S. International Trade Commission (USITC) to analyze import/export dynamics.
Financial databases including Bloomberg, Factiva, Hoovers, and PitchBook were used to assess company financials and strategic moves.

Demand Modeling & Market Estimation

We employed a bottom-up approach to estimate market size, starting with procedure volumes and average selling prices (ASPs) for BT catheters across key regions.
Top-down validation was performed using regional healthcare expenditure data and device penetration rates.
Multi-level data triangulation was applied to reconcile discrepancies between primary and secondary data sources, ensuring consistency.
Key quantitative metrics used in the model include: number of BT procedures performed annually, average catheter price per procedure, catheter replacement rates, and hospital adoption rates.

Data Accuracy & Quality Check

Our proprietary quality assurance process guarantees an estimated data accuracy level of 85–90%.
All data points were cross-validated through three rounds of expert review and compared against historical market trends and clinical trial outcomes.
Every report is updated to the date of purchase, incorporating the latest market developments and regulatory changes.
We maintain a comprehensive error-check protocol to eliminate biases and ensure the reliability of all forecasts.

Frequently Asked Questions

1. What is the current market size of the bronchial thermoplasty catheter market?

The global bronchial thermoplasty catheter market was valued at USD 4.8 billion in 2025 and is projected to reach USD 7.7 billion by 2035, growing at a CAGR of 5.5%.

2. Which region dominates the bronchial thermoplasty catheter market?

North America holds the largest share, accounting for approximately 39% of the global market by 2035, driven by high severe asthma prevalence and favorable reimbursement policies.

3. What are the key factors driving the growth of the bronchial thermoplasty catheter market?

Key drivers include the rising prevalence of severe asthma, increasing asthma-related mortality, preference for minimally invasive procedures, and supportive healthcare policies.

4. Who are the major players in the bronchial thermoplasty catheter market?

Leading companies include Boston Scientific Corporation, Medtronic plc, Olympus Corporation, Abbott Laboratories, Johnson & Johnson, Teleflex Incorporated, Cook Medical LLC, and Terumo Corporation, among others.

5. What is the cost of a bronchial thermoplasty procedure?

In the U.S., bronchial thermoplasty typically costs between USD 15,000 and USD 20,000 per patient, and coverage varies widely among insurance providers.

6. What are the challenges faced by the bronchial thermoplasty catheter market?

Major challenges include high procedure costs, limited reimbursement, need for skilled operators, and potential side effects such as transient asthma worsening.

7. What are the recent developments in the bronchial thermoplasty catheter market?

Recent developments include Boston Scientific's continued commercial expansion of its Alair system (February 2024) and Medtronic's portfolio optimization to focus on respiratory and airway management technologies (March 2024).

Choose License Type

Author

Amit Mardhekar

Research Analyst

I am a Research Analyst driving market intelligence at the intersection of Healthcare, Life Sciences, Materials, and Real Estate and Construction landscapes. Specializing in Pharmaceuticals, Medical Devices, and Construction infrastructure, my expertise lies in market sizing, trend analysis, and demand forecasting. I focus on translating regulatory shifts and complex industry trends into strategic insights that help global clients identify and confidently seize new growth opportunities.

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Client Reviews

5.0

Verified Purchase

“As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team. ”

Shankar Godavarti

Verified

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

Verified Purchase

“I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you again for a good quality report ”

Jared Wan

Verified

Analyst at Providence Strategic Partners at Petaling Jaya

Verified Purchase

“The response was good, and I got what I was looking for as far as the report. Thank you for that.”

Erik Perison

Verified

US TPS Business Development Manager at Thermon

Verified Purchase

“Yes, as a matter of fact we are totally satisfied with both reports that we have purchased and will continue to do so during this process of the internationalization of our brand.”

Santiago Mejia Molina

Verified

Internationalization Director

Verified Purchase

“We are using your report, and it gave us valuable information." ”

Olaf Gleibe

Verified

Head of Product Management and Marketing

1/5

About Market Lens IQ

Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.

At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.

Executive Overview

Bronchial Thermoplasty Catheter Market Size (In Billion)

7.5B

6.0B

4.5B

3.0B

1.5B

4.800 B

2025

5.064 B

2026

5.343 B

2027

5.636 B

2028

5.946 B

2029

6.273 B

2030

6.618 B

2031

Tailored for you